相关实验视频
Updated: Feb 13, 2026

10:29
Generation of Human Chimeric Antigen Receptor Regulatory T Cells
Published on: January 3, 2025
2.5K
化学抗原受体T细胞治疗血液恶性瘤后的长期存活率
Rawan G Faramand1, Zhuoer Xie2, Michael D Jain1
1Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL.
概括
化学抗原受体 (CAR) T细胞治疗改善了血液癌症的存活率. 长期幸存者面临感染和二次癌症等风险,需要专门的护理和进一步的研究.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 化学抗原受体 (CAR) T细胞疗法在治疗血液性恶性瘤方面显示出有效性.
- 长期接受CAR T细胞治疗的幸存者面临重大风险,包括感染和二次髓状细胞恶性瘤.
- 幸存者往往有复杂的需求,由于先前的治疗,如化疗,放射和干细胞移植.
研究的目的:
- 为在CAR T细胞治疗后长期缓解患者的管理提供路线图.
- 确定和讨论这些患者的关键生存需求.
- 概述CAR T细胞治疗生存率的未来研究方向.
主要方法:
- 临床试验和现实世界的证据对CAR T细胞治疗结果的审查.
- 对长期不良事件和生存挑战的分析.
- 综合当前的知识,提出一个护理路线图.
主要成果:
- 卡尔T细胞疗法有效地减少了血液性恶性瘤的进展,并可以增加存活率.
- 长期缓解的患者容易感染和非复发性死亡率.
- 幸存者护理必须解决潜在的长期疾病和二次恶性瘤.
结论:
- 在CAR T细胞治疗后长期缓解的患者需要专业护理.
- 解决感染,二次恶性瘤和更广泛的生存需求至关重要.
- 需要进一步的研究,以优化CAR T细胞治疗幸存者的长期结果和生活质量.
相关概念视频
Diversity of Antigen Receptors
1.7K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.7K
Antigen Presenting Cells
3.4K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
3.4K
Long-term Depression
33.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.4K
Types of Receptors: Cell Surface Receptors
27.6K
Cell-surface receptors, also known as transmembrane receptors, are cell surface, membrane-anchored (integral) proteins that bind to external ligand molecules. This type of receptor spans the plasma membrane and performs signal transduction, converting an extracellular signal into an intracellular signal. Ligands that interact with cell-surface receptors do not have to enter the cell that they affect. Cell-surface receptors are also called cell-specific proteins or markers because they are...
27.6K
Internal Receptors
74.7K
Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K

